• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Otani Sakiko  大谷 咲子

ORCIDConnect your ORCID iD *help
Researcher Number 60439081
Other IDs
Affiliation (based on the past Project Information) *help 2020 – 2021: 北里大学, 医学部, 助教
Review Section/Research Field
Principal Investigator
Basic Section 53030:Respiratory medicine-related
Keywords
Principal Investigator
薬剤耐性 / オシメルチニブ / MEK阻害薬 / 髄膜がん腫症SCIDマウス / KRAS変異 / EGFR変異肺癌 / オシメルチニブ耐性 / 髄膜癌腫症 / EGFR陽性肺癌
  • Research Projects

    (1 results)
  • Research Products

    (1 results)
  •  osimertinib resistance leptomeningeal carcinomatosis model of EGFR-mutant modelPrincipal Investigator

    • Principal Investigator
      Otani Sakiko
    • Project Period (FY)
      2020 – 2021
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 53030:Respiratory medicine-related
    • Research Institution
      Kitasato University

All 2021

All Journal Article

  • [Journal Article] Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer2021

    • Author(s)
      Fukuda Koji、Otani Sakiko、Takeuchi Shinji、Arai Sachiko、Nanjo Shigeki、Tanimoto Azusa、Nishiyama Akihiro、Naoki Katsuhiko、Yano Seiji
    • Journal Title

      Cancer Science

      Volume: 112 Issue: 9 Pages: 3784-3795

    • DOI

      10.1111/cas.15035

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K17213, KAKENHI-PROJECT-19H03665, KAKENHI-PROJECT-21K07172

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi